Department of Surgey, Cantonal Hospital St. Gallen
Sankt Gallen, 9007, Switzerland
NCT Number: NCT01069016
Sacral nerve modulation (SNM) is an established treatment for refractory lower urinary tract and bowel dysfunction (Spinelli 2008). Pudendal nerve stimulation (PNS) has been proposed for patients failing SNM treatment of urinary dysfunction (Spinelli 2005). In this study SNM and PNS are compared for the treatment of fecal incontinence. In a test phase, both treatments will be applied for one week each in a randomized and blinded order (cross-over design). After the test phase the more successful treatment will be determined and applied permanently. If both treatments are equally sufficient, PNS will be chosen for permanent stimulation, since preliminary data indicate that PNS has a lower power consumption than SNM. Lower power consumption results in a longer lifetime of the stimulator, thus requiring less replacement surgeries.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Sankt Gallen, 9007, Switzerland
Primary Surgery:
Test phase:
Secondary surgery:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For one week the sacral nerve is continuously stimulated by an external pulse generator. Strength of stimulation can be adjusted by the patient.
Other names: SNM, Sacral nerve stimulation, SNS
For one week the pudendal nerve is continuously stimulated by an external pulse generator. Strength of stimulation can be adjusted by the patient.
Other names: PNS
Time frame: 14 days
Time frame: 7, 14 days, 3, 6 & 12 months
Time frame: 30 days
Time frame: 14 days, 3, 6 & 12 months
Cantonal Hospital of St. Gallen
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04806386
Colonic Diseases, Colonic Diseases, Functional
Boston, Massachusetts, United States
View Trial DetailsNCT00213317
Colonic Diseases, Colonic Diseases, Functional
Rouen, France
View Trial DetailsNCT01786304
Digestive System Diseases, Fecal Incontinence
Rouen, Normandy, France
View Trial DetailsNCT05773742
Constipation, Digestive System Diseases
Aarhus, Denmark
View Trial Details